Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 9598) to amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes, as amended. Mr. Speaker, I ask unanimous…
Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 9598) to amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes, as amended.
Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material on this measure.
Mr. Speaker, I yield myself such time as I may consume.
Mr. Speaker, I rise in support of this bill, the Office of National Drug Control Policy Reauthorization Act.
We have a drug overdose crisis in this country. It is unacceptable and intolerable. In 2019, roughly 70,000 people in the United States died of an overdose. In 2021, that number rose to over 106,000, and in 2022, to over 111,000 deaths.
In 2023, overdose deaths remained over 100,000 with 107,000 Americans dying of an overdose. Overdose deaths remain near record highs. This is an ongoing, deadly national emergency that affects every community in our Nation.
The Office of National Drug Control Policy, or ONDCP, was established in the Executive Office of the President with the specific mission to coordinate the government-wide resources to combat the loss of life and human misery caused by illicit narcotics and overdoses.
This bill, the Office of National Drug Control Policy Reauthorization Act of 2024, will reauthorize ONDCP and two critical grant programs the office administers at current spending levels for the next 7 years.
Specifically, the bill will reauthorize the High Intensity Drug Trafficking Areas Program, which helps local law enforcement coordinate efforts to take down drug traffickers, and the Drug Free Communities Program, which works in communities across the country to prevent young people from ever trying drugs in the first place.
I commend the great Americans who work hard to get results through the Drug Free Communities coalitions. We listen to these coalitions and ensure that the grant limitation for local communities was increased from $125,000 to $150,000 and gave the ONDCP Director the ability to award up to two additional grants to eligible coalitions rather than the previous limit of one.
I thank Congressman John Duarte of California and Congresswoman Elissa Slotkin of Michigan for their efforts to reauthorize HIDTA. Key elements of this bipartisan bill, H.R. 7185, have been incorporated into this reauthorization bill to ensure that HIDTA resources are used to combat fentanyl, including granting the Attorney General the authority to temporarily reassign U.S. attorneys to prioritize fentanyl trafficking.
I am sure that every single member of this committee and every Member of this Congress knows constituents and their families who have been tragically impacted by illicit narcotics, especially synthetic opioids like fentanyl. No drug has affected our communities more in recent years than fentanyl.
The DEA has assessed that virtually all of the deadly fentanyl found in the United States is mass-produced by transnational criminal organizations in Mexico using precursor chemicals sourced from China and then smuggled into the United States across the southwest border.
This bill requires the Secretary of Homeland Security to assess how an increase in encounters at the southwest border affects DHS' ability to prevent the unlawful entry of fentanyl and other illicit drugs into the United States.
It also directs the ONDCP Director to coordinate with the Departments of Homeland Security, Justice, and State to ensure that the appropriate agencies are properly resourced to ensure that traffickers of illicit drugs are held accountable under title 8 immigration authorities.
I thank Congresswoman Gonzalez-Colon of Puerto Rico and Congresswoman Stacey Plaskett of the U.S. Virgin Islands for their work on H.R. 920, and ensuring that the Caribbean Border Counternarcotics Strategy is codified in this reauthorization package ensuring that ONDCP will properly assess the threat of drug trafficking into the United States through the Caribbean.
I thank Ranking Member Raskin and his staff for working with us to make this important bill a reality over the past year.
H.R. 9598 represents an important reauthorization effort in the House Committee on Oversight and Accountability's legislative jurisdiction. I also thank the chairs and ranking members of the Energy and Commerce Committee and House Judiciary Committee and their professional staff for closely coordinating on our shared jurisdiction within this bill.
Mr. Speaker, I urge all of my colleagues to support this bipartisan bill so we can keep the U.S. Government's collective resources focused on addressing the national drug crisis in our great country.
Mr. Speaker, I reserve the balance of my time.
Mr. Speaker, I yield 5 minutes to the gentlewoman from Puerto Rico (Mrs. Gonzalez-Colon).
Mr. Speaker, I yield 5 minutes to the gentleman from California (Mr. Duarte).
Mr. Speaker, I encourage my colleagues to support this very important legislation, and I yield back the balance of my time.
Mr. Speaker, on that I demand the yeas and nays.